A prospective, multicentre study on the use of epidermal grafts to optimise outpatient wound management

• DOI: 10.1111/iwj.12595
• Publication Date: 2016-03-21T01:22:46Z
• Authors: Nadine Hachach‐Haram; Nicola Bystrzonowski; Muholan Kanapathy; Oliver Smith; Keith Harding; Ash Mosahebi; Toby Richards
• Keywords: Skin grafting; Wound care; Outpatient clinic; Chronic wound

ABSTRACT Current wound management through the use of a split‐thickness skin graft often requires hospital admission, period immobility, attentive donor site care and pain management. This study evaluates feasibility using novel epidermal graft‐harvesting device ( CelluTome ) that allows pain‐free grafting in outpatient clinic setting. A prospective series 35 patients was performed 2 centres, involving 10 acute 25 chronic wounds. All were subjected to specialist clinic, without anaesthesia, allowed return home after procedure. Completely healed wounds noted 22 (62·9%). The overall mean time for 50% 100% reduction size 3·31 ± 2·33 5·91 3·48 weeks, respectively. There no significant difference healing times between (50% size; 2·20 0·91 weeks versus 3·73 2·63 P = 0·171. Hundred percent 4·80 1·61 6·83 4·47 0·183). 5·49 1·48 days. score during harvest 1·42 0·95, Vancouver Scar Scale 0 all cases at 6 weeks. automated offers autologous harvesting setting with minimal or scar free site, equally benefiting both It has potential save NHS resources by eliminating need theatre space bed while same patient care.